HuGE Literature Finder
|
||
Records 1-18
|
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.
Journal of the American Academy of Dermatology 2018 Sep . Dalmasso Bruna, Pastorino Lorenza, Ciccarese Giulia, Andreotti Virginia, Grillo Federica, Mastracci Luca, Spagnolo Francesco, Ballestrero Alberto, Queirolo Paola, Bruno William, Ghiorzo Pao |
|
Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
JAMA dermatology 2015 Dec 1-8. Potrony Miriam, Puig-Butille Joan Anton, Aguilera Paula, Badenas Celia, Tell-Marti Gemma, Carrera Cristina, Javier Del Pozo Luis, Conejo-Mir Julian, Malvehy Josep, Puig Susa |
|
Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.
BMC research notes 2015 8 264. Potjer Thomas P, van der Stoep Nienke, Houwing-Duistermaat Jeanine J, Konings Ingrid C A W, Aalfs Cora M, van den Akker Peter C, Ausems Margreet G, Dommering Charlotte J, van der Kolk Lizet E, Maiburg Merel C, Spruijt Liesbeth, Wagner Anja, Vasen Hans F A, Hes Frederik |
|
Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families.
The Journal of investigative dermatology 2014 Feb 134 (2): 481-7. Liang Xueying, Pfeiffer Ruth M, Li Wen-Qing, Brossard Myriam, Burke Laura S, Wheeler William, Calista Donato, Fargnoli Maria Concetta, Ghiorzo Paola, Peris Ketty, Bianchi-Scarra Giovanna, Chaudru Valerie, Zelenika Diana, Maeder Dennis, Burdette Laurie, Yeager Meredith, Chanock Stephen, Landi Maria Teresa, Demenais Florence, Tucker Margaret A, Goldstein Alisa M, Yang Xiaohong |
|
Genital and anorectal mucosal melanoma is associated with cutaneous melanoma in patients and in families.
The British journal of dermatology 2013 Sep 169 (3): 594-9. Cazenave H, Maubec E, Mohamdi H, Grange F, Bressac-de Paillerets B, Demenais F, Avril M |
|
CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.
Experimental dermatology 2013 Jun 22 (6): 411-6. Bassoli Sara, Maurichi Andrea, Rodolfo Monica, Casari Alice, Frigerio Simona, Pupelli Gaia, Farnetani Francesca, Pelosi Giuseppe, Santinami Mario, Pellacani Giovan |
|
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
Experimental dermatology 2012 Sep 21 (9): 718-20. Ghiorzo Paola, Bonelli Luigina, Pastorino Lorenza, Bruno William, Barile Monica, Andreotti Virginia, Nasti Sabina, Battistuzzi Linda, Grosso Marco, Bianchi-Scarrà Giovanna, Queirolo Pao |
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3.
Nature genetics 2011 Nov 43 (11): 1114-8. Macgregor Stuart, Montgomery Grant W, Liu Jimmy Z, Zhao Zhen Zhen, Henders Anjali K, Stark Mitchell, Schmid Helen, Holland Elizabeth A, Duffy David L, Zhang Mingfeng, Painter Jodie N, Nyholt Dale R, Maskiell Judith A, Jetann Jodie, Ferguson Megan, Cust Anne E, Jenkins Mark A, Whiteman David C, Olsson Håkan, Puig Susana, Bianchi-Scarrà Giovanna, Hansson Johan, Demenais Florence, Landi Maria Teresa, D?bniak Tadeusz, Mackie Rona, Azizi Esther, Bressac-de Paillerets Brigitte, Goldstein Alisa M, Kanetsky Peter A, Gruis Nelleke A, Elder David E, Newton-Bishop Julia A, Bishop D Timothy, Iles Mark M, Helsing Per, Amos Christopher I, Wei Qingyi, Wang Li-E, Lee Jeffrey E, Qureshi Abrar A, Kefford Richard F, Giles Graham G, Armstrong Bruce K, Aitken Joanne F, Han Jiali, Hopper John L, Trent Jeffrey M, Brown Kevin M, Martin Nicholas G, Mann Graham J, Hayward Nicholas |
|
Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Familial cancer 2010 Dec 9 (4): 625-33. Yang Xiaohong Rose, Liang Xueying, Pfeiffer Ruth M, Wheeler William, Maeder Dennis, Burdette Laurie, Yeager Meredith, Chanock Stephen, Tucker Margaret A, Goldstein Alisa |
|
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Journal of the National Cancer Institute 2010 Oct 102 (20): 1568-83. Demenais F, Mohamdi H, Chaudru V, Goldstein A M, Newton Bishop J A, Bishop D T, Kanetsky P A, Hayward N K, Gillanders E, Elder D E, Avril M F, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland E A, Ingvar C, Landi M T, Lang J M, Mackie R M, Mann G J, Ming M E, Njauw C J, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker M A, van der Velden P, Yang X R, Gruis N, |
|
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Melanoma research 2010 Aug 20 (4): 266-72. Nielsen Kari, Harbst Katja, Måsbäck Anna, Jönsson Göran, Borg Ake, Olsson Håkan, Ingvar Christi |
|
IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
American journal of human genetics 2010 Jul 87 (1): 6-16. Duffy David L, Iles Mark M, Glass Dan, Zhu Gu, Barrett Jennifer H, Höiom Veronica, Zhao Zhen Z, Sturm Richard A, Soranzo Nicole, Hammond Chris, Kvaskoff Marina, Whiteman David C, Mangino Massimo, Hansson Johan, Newton-Bishop Julia A, , Bataille Veronique, Hayward Nicholas K, Martin Nicholas G, Bishop D Timothy, Spector Timothy D, Montgomery Grant |
|
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
Nature genetics 2009 Aug 41 (8): 915-9. Falchi Mario, Bataille Veronique, Hayward Nicholas K, Duffy David L, Bishop Julia A Newton, Pastinen Tomi, Cervino Alessandra, Zhao Zhen Z, Deloukas Panos, Soranzo Nicole, Elder David E, Barrett Jennifer H, Martin Nicholas G, Bishop D Timothy, Montgomery Grant W, Spector Timothy |
|
Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
International journal of cancer. Journal international du cancer 2007 Aug 121 (4): 825-31. Goldstein Alisa M, Chaudru Valerie, Ghiorzo Paola, Badenas Celia, Malvehy Josep, Pastorino Lorenza, Laud Karine, Hulley Benjamin, Avril Marie-Francoise, Puig-Butille Joan A, Miniere Annie, Marti Rosa, Chompret Agnes, Cuellar Francisco, Kolm Isabel, Mila Montserrat, Tucker Margaret A, Demenais Florence, Bianchi-Scarra Giovanna, Puig Susana, de-Paillerets Brigitte Bress |
|
BRAF polymorphisms and risk of melanocytic neoplasia.
The Journal of investigative dermatology 2005 Dec 125 (6): 1252-8. James Michael R, Roth Richard B, Shi Michael M, Kammerer Stefan, Nelson Matthew R, Stark Mitchell S, Dumenil Troy, Montgomery Grant W, Hayward Nicholas K, Martin Nicholas G, Braun Andreas, Duffy David |
|
Estimating the relative risk of developing melanoma in INK4A carriers.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2004 Feb 13 (1): 65-70. Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady MS, Roy P, Song Y, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg CB |
|
An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.
The Journal of investigative dermatology 2002 Oct 119 (4): 961-5. Bertram Chandra G, Gaut Rupert M, Barrett Jennifer H, Pinney Elizabeth, Whitaker Linda, Turner Faye, Bataille Veronique, Dos Santos Silva Isabel, J Swerdlow Anthony, Bishop D Timothy, Newton Bishop Julia |
|
Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000 Sep 9 (9): 889-94. Goldstein A M, Martinez M, Tucker M A, Demenais |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 18, 2019
- Content source: